BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 33860709)

  • 1. Cannabidiol modulation of hippocampal glutamate in early psychosis.
    O'Neill A; Annibale L; Blest-Hopley G; Wilson R; Giampietro V; Bhattacharyya S
    J Psychopharmacol; 2021 Jul; 35(7):814-822. PubMed ID: 33860709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis.
    O'Neill A; Wilson R; Blest-Hopley G; Annibale L; Colizzi M; Brammer M; Giampietro V; Bhattacharyya S
    Psychol Med; 2021 Mar; 51(4):596-606. PubMed ID: 31994476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data.
    Merritt K; McGuire PK; Egerton A; ; Aleman A; Block W; Bloemen OJN; Borgan F; Bustillo JR; Capizzano AA; Coughlin JM; De la Fuente-Sandoval C; Demjaha A; Dempster K; Do KQ; Du F; Falkai P; Galinska-Skok B; Gallinat J; Gasparovic C; Ginestet CE; Goto N; Graff-Guerrero A; Ho BC; Howes OD; Jauhar S; Jeon P; Kato T; Kaufmann CA; Kegeles LS; Keshavan M; Kim SY; Kunugi H; Lauriello J; Liemburg EJ; Mcilwain ME; Modinos G; Mouchlianitis ED; Nakamura J; Nenadic I; Öngür D; Ota M; Palaniyappan L; Pantelis C; Plitman E; Posporelis S; Purdon SE; Reichenbach JR; Renshaw PF; Russell BR; Sawa A; Schaefer M; Shungu DC; Smesny S; Stanley JA; Stone JM; Szulc A; Taylor R; Thakkar K; Théberge J; Tibbo PG; van Amelsvoort T; Walecki J; Williamson PC; Wood SJ; Xin L; Yamasue H
    JAMA Psychiatry; 2021 Jun; 78(6):667-681. PubMed ID: 33881460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippocampal glutamate metabolites and glial activation in clinical high risk and first episode psychosis.
    Shakory S; Watts JJ; Hafizi S; Da Silva T; Khan S; Kiang M; Bagby RM; Chavez S; Mizrahi R
    Neuropsychopharmacology; 2018 Oct; 43(11):2249-2255. PubMed ID: 30087434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA).
    Egerton A; Murphy A; Donocik J; Anton A; Barker GJ; Collier T; Deakin B; Drake R; Eliasson E; Emsley R; Gregory CJ; Griffiths K; Kapur S; Kassoumeri L; Knight L; Lambe EJB; Lawrie SM; Lees J; Lewis S; Lythgoe DJ; Matthews J; McGuire P; McNamee L; Semple S; Shaw AD; Singh KD; Stockton-Powdrell C; Talbot PS; Veronese M; Wagner E; Walters JTR; Williams SR; MacCabe JH; Howes OD
    Schizophr Bull; 2021 Mar; 47(2):505-516. PubMed ID: 32910150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurochemical effects of oxytocin in people at clinical high risk for psychosis.
    Davies C; Rutigliano G; De Micheli A; Stone JM; Ramella-Cravaro V; Provenzani U; Cappucciati M; Scutt E; Paloyelis Y; Oliver D; Murguia S; Zelaya F; Allen P; Shergill S; Morrison P; Williams S; Taylor D; Lythgoe DJ; McGuire P; Fusar-Poli P
    Eur Neuropsychopharmacol; 2019 May; 29(5):601-615. PubMed ID: 30928180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Hippocampal Glutamate Levels With Adverse Outcomes in Individuals at Clinical High Risk for Psychosis.
    Bossong MG; Antoniades M; Azis M; Samson C; Quinn B; Bonoldi I; Modinos G; Perez J; Howes OD; Stone JM; Allen P; McGuire P
    JAMA Psychiatry; 2019 Feb; 76(2):199-207. PubMed ID: 30427993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neural Signatures of Memory Encoding in Schizophrenia Are Modulated by Antipsychotic Treatment.
    Gurler D; White DM; Kraguljac NV; Ver Hoef L; Martin C; Tennant B; Lahti AC
    Neuropsychobiology; 2021; 80(1):12-24. PubMed ID: 32316023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anterior cingulate glutamate metabolites as a predictor of antipsychotic response in first episode psychosis: data from the STRATA collaboration.
    Egerton A; Griffiths K; Casetta C; Deakin B; Drake R; Howes OD; Kassoumeri L; Khan S; Lankshear S; Lees J; Lewis S; Mikulskaya E; Millgate E; Oloyede E; Pollard R; Rich N; Segev A; Sendt KV; MacCabe JH
    Neuropsychopharmacology; 2023 Feb; 48(3):567-575. PubMed ID: 36456813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabidiol improves behavioural and neurochemical deficits in adult female offspring of the maternal immune activation (poly I:C) model of neurodevelopmental disorders.
    Osborne AL; Solowij N; Babic I; Lum JS; Huang XF; Newell KA; Weston-Green K
    Brain Behav Immun; 2019 Oct; 81():574-587. PubMed ID: 31326506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Brain Glutamate on Switching to Clozapine in Treatment-Resistant Schizophrenia.
    McQueen G; Sendt KV; Gillespie A; Avila A; Lally J; Vallianatou K; Chang N; Ferreira D; Borgan F; Howes OD; Barker GJ; Lythgoe DJ; Stone JM; McGuire P; MacCabe JH; Egerton A
    Schizophr Bull; 2021 Apr; 47(3):662-671. PubMed ID: 33398325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cannabidiol on endocannabinoid, glutamatergic and GABAergic signalling markers in male offspring of a maternal immune activation (poly I:C) model relevant to schizophrenia.
    Osborne AL; Solowij N; Babic I; Lum JS; Newell KA; Huang XF; Weston-Green K
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109666. PubMed ID: 31202911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study.
    de la Fuente-Sandoval C; León-Ortiz P; Azcárraga M; Stephano S; Favila R; Díaz-Galvis L; Alvarado-Alanis P; Ramírez-Bermúdez J; Graff-Guerrero A
    JAMA Psychiatry; 2013 Oct; 70(10):1057-66. PubMed ID: 23966023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hippocampal Pathology in Clinical High-Risk Patients and the Onset of Schizophrenia.
    Provenzano FA; Guo J; Wall MM; Feng X; Sigmon HC; Brucato G; First MB; Rothman DL; Girgis RR; Lieberman JA; Small SA
    Biol Psychiatry; 2020 Feb; 87(3):234-242. PubMed ID: 31771861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticolimbic hyper-response to emotion and glutamatergic function in people with high schizotypy: a multimodal fMRI-MRS study.
    Modinos G; McLaughlin A; Egerton A; McMullen K; Kumari V; Barker GJ; Keysers C; Williams SC
    Transl Psychiatry; 2017 Apr; 7(4):e1083. PubMed ID: 28375210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosis.
    Stone JM; Howes OD; Egerton A; Kambeitz J; Allen P; Lythgoe DJ; O'Gorman RL; McLean MA; Barker GJ; McGuire P
    Biol Psychiatry; 2010 Oct; 68(7):599-602. PubMed ID: 20638047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippocampal glutamate and hippocampus subfield volumes in antipsychotic-naive first episode psychosis subjects and relationships to duration of untreated psychosis.
    Briend F; Nelson EA; Maximo O; Armstrong WP; Kraguljac NV; Lahti AC
    Transl Psychiatry; 2020 May; 10(1):137. PubMed ID: 32398671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early treatment response in first episode psychosis: a 7-T magnetic resonance spectroscopic study of glutathione and glutamate.
    Dempster K; Jeon P; MacKinley M; Williamson P; Théberge J; Palaniyappan L
    Mol Psychiatry; 2020 Aug; 25(8):1640-1650. PubMed ID: 32205866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naïve patients with psychosis.
    Bojesen KB; Ebdrup BH; Jessen K; Sigvard A; Tangmose K; Edden RAE; Larsson HBW; Rostrup E; Broberg BV; Glenthøj BY
    Psychol Med; 2020 Oct; 50(13):2182-2193. PubMed ID: 31524118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre
    Egerton A; Broberg BV; Van Haren N; Merritt K; Barker GJ; Lythgoe DJ; Perez-Iglesias R; Baandrup L; Düring SW; Sendt KV; Stone JM; Rostrup E; Sommer IE; Glenthøj B; Kahn RS; Dazzan P; McGuire P
    Mol Psychiatry; 2018 Nov; 23(11):2145-2155. PubMed ID: 29880882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.